ganirelix acetate
Sponsors
University of Pennsylvania, Yale University, Yazd Research & Clinical Center for Infertility, University of California, San Francisco, LG Life Sciences
Conditions
Cerebral Arterial DiseasesControlled Ovarian StimulationDiminished Ovarian ReserveEstrogenExercise Induced HyponatremiaIVFIn Vitro FertilizationInfertility
Early Phase 1
Phase 1
Phase 2
Phase 4
Luteal Phase FSH in the IVF Poor Responder
CompletedNCT00225433
Start: 2005-09-30End: 2008-06-30Updated: 2015-12-03
Delayed Start to Ovarian Stimulation
TerminatedNCT01614067
Start: 2012-05-31End: 2014-09-30Updated: 2021-06-15
To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®
CompletedNCT03051087
Start: 2016-10-31End: 2018-03-31Updated: 2019-07-02
Cetrorelix and Ganirelix Flexible Protocol for (IVF)
NCT03477929
Start: 2017-11-15End: 2019-01-15Target: 100Updated: 2018-03-27
The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles
NCT04654741
Start: 2020-09-01End: 2022-12-31Target: 396Updated: 2020-12-04
Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.
CompletedNCT05954962
Start: 2023-12-23End: 2025-08-30Updated: 2026-03-27
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
RecruitingNCT06745466
Start: 2024-11-15End: 2027-10-31Target: 30Updated: 2024-12-20